Type | Public | |
Founded | 1996 | |
HQ | Basel, CH | Map |
Website | novartis.com | |
Employee Ratings | More |
USD | |
---|---|
Revenue (Q3, 2020) | 12.3b |
Gross profit (Q3, 2020) | 8.5b |
Gross profit margin (Q3, 2020), % | 69.4% |
Net income (Q3, 2020) | 1.9b |
EBIT (Q3, 2020) | 2.4b |
Market capitalization (15-Jan-2021) | 194.0b |
Closing stock price (15-Jan-2021) | 85.3 |
Cash (30-Sept-2020) | 9.0b |
EV | 223.2b |
USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|
Net Income | 2.0b | 9.8b | 11.4b | 1.9b | 4.0b | 6.0b | 2.2b | 4.0b | 6.0b |
Depreciation and Amortization | 4.9b | 1.4b | 2.5b | 3.9b | 1.4b | 3.1b | |||
Cash From Operating Activities | 2.5b | 6.5b | 10.5b | 2.4b | 5.5b | 10.1b | 2.5b | 6.5b | 9.6b |
Purchases of PP&E | (359.0m) | (690.0m) | (1.1b) | (282.0m) | (561.0m) | (918.0m) | (237.0m) | (475.0m) | (754.0m) |
USD | FY, 2017 |
---|---|
EV/EBIT | 22.6 x |
EV/CFO | 15.5 x |
Revenue/Employee | 403.9k |
Debt/Equity | 0.4 x |
Debt/Assets | 0.2 x |
Financial Leverage | 1.8 x |
P/E Ratio | 22.2 |
Company Name | Date | Deal Size |
---|---|---|
Vedere Bio | October 29, 2020 | $280 m |
Amblyotech | April 21, 2020 | |
The Medicines Company | November 25, 2019 | $9.70 b |
Xiidra | May 09, 2019 | $1.90 b |
Novartis Inflammasome Research | April 02, 2019 | $1.58 b |
CellforCure | December 21, 2018 | |
Endocyte | October 18, 2018 | |
AveXis | April 09, 2018 | $8.70 b |
Advanced Accelerator Applications | October 30, 2017 | $3.90 b |
Encore Vision | December 20, 2016 |
Novartis revenue breakdown by business segment: 20.5% from Sandoz and 79.5% from Innovative Medicines
Novartis revenue breakdown by geographic segment: 5.6% from Japan , 34.3% from United States, 5.1% from France, 8.7% from Germany and 46.3% from Other
Novartis has 284.7k Twitter Followers. The number of followers has increased 0.6% month over month and increased 2% quarter over quarter
12.4k
Tweets
569
Following
284.7k
Followers
17
Tweets last 30 days
1.4
Avg. likes per Tweet
29.4%
Tweets with engagement
When was Novartis founded?
Novartis was founded in 1996.
Who are Novartis key executives?
Novartis's key executives are Vasant Narasimhan, Joerg Reinhardt and Bertrand Bodson.
How many employees does Novartis have?
Novartis has 103,914 employees.
What is Novartis revenue?
Latest Novartis annual revenue is $47.4 b.
What is Novartis revenue per employee?
Latest Novartis revenue per employee is $456.6 k.
Who are Novartis competitors?
Competitors of Novartis include Bausch + Lomb, Immunomedics and Gilead Sciences.
Where is Novartis headquarters?
Novartis headquarters is located at Fabrikstrasse 2, Basel.
Where are Novartis offices?
Novartis has offices in Basel, Schweizerhalle, Stein, Broomfield and in 164 other locations.
How many offices does Novartis have?
Novartis has 181 offices.
Receive alerts for 300+ data fields across thousands of companies